12/26
09:02 am
agio
Agios Pharmaceuticals (NASDAQ:AGIO) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
Agios Pharmaceuticals (NASDAQ:AGIO) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
12/26
08:04 am
agio
Agios Pharmaceuticals (NASDAQ:AGIO) was given a new $40.00 price target on by analysts at Leerink Partners.
Medium
Report
Agios Pharmaceuticals (NASDAQ:AGIO) was given a new $40.00 price target on by analysts at Leerink Partners.
12/25
10:47 am
agio
Agios (AGIO) Gets 18.6% Boost from Aqvesme OK [Yahoo! Finance]
Medium
Report
Agios (AGIO) Gets 18.6% Boost from Aqvesme OK [Yahoo! Finance]
12/24
05:02 pm
agio
Agios Pharmaceuticals, Inc. (AGIO) Discusses FDA Approval of AQVESME for Anemia in Alpha and Beta Thalassemia Transcript [Seeking Alpha]
Medium
Report
Agios Pharmaceuticals, Inc. (AGIO) Discusses FDA Approval of AQVESME for Anemia in Alpha and Beta Thalassemia Transcript [Seeking Alpha]
12/24
02:01 pm
agio
Agios Pharmaceuticals (NASDAQ:AGIO) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Neutral
Report
Agios Pharmaceuticals (NASDAQ:AGIO) had its "buy" rating reaffirmed by analysts at HC Wainwright.
12/24
01:14 pm
agio
Agios Pharmaceuticals (NASDAQ:AGIO) had its price target raised by analysts at Truist Financial Corporation from $32.00 to $38.00. They now have a "buy" rating on the stock.
Neutral
Report
Agios Pharmaceuticals (NASDAQ:AGIO) had its price target raised by analysts at Truist Financial Corporation from $32.00 to $38.00. They now have a "buy" rating on the stock.
12/24
12:33 pm
agio
Here's Why Shares in Agios Pharmaceuticals Popped Today [Yahoo! Finance]
Low
Report
Here's Why Shares in Agios Pharmaceuticals Popped Today [Yahoo! Finance]
12/24
08:43 am
agio
Agios Pharmaceuticals (NASDAQ:AGIO) had its price target raised by analysts at Bank of America Corporation from $32.00 to $34.00. They now have a "buy" rating on the stock.
Medium
Report
Agios Pharmaceuticals (NASDAQ:AGIO) had its price target raised by analysts at Bank of America Corporation from $32.00 to $34.00. They now have a "buy" rating on the stock.
12/23
07:45 pm
agio
U.S. FDA Approves Agios’ AQVESME™ (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia
High
Report
U.S. FDA Approves Agios’ AQVESME™ (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia
12/8
07:00 am
agio
Agios Provides Update on U.S. sNDA for Mitapivat in Thalassemia
Low
Report
Agios Provides Update on U.S. sNDA for Mitapivat in Thalassemia
12/5
10:29 pm
agio
How The Latest Trial And FDA Risk Shift The Story For Agios Pharmaceuticals [Yahoo! Finance]
Low
Report
How The Latest Trial And FDA Risk Shift The Story For Agios Pharmaceuticals [Yahoo! Finance]
11/29
07:16 am
agio
Agios Pharmaceuticals (NASDAQ:AGIO) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.
Medium
Report
Agios Pharmaceuticals (NASDAQ:AGIO) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.
11/26
02:01 pm
agio
Agios Pharmaceuticals (NASDAQ:AGIO) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Agios Pharmaceuticals (NASDAQ:AGIO) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
11/26
06:04 am
agio
Agios Pharmaceuticals (NASDAQ:AGIO) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.
Low
Report
Agios Pharmaceuticals (NASDAQ:AGIO) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.
11/25
08:53 am
agio
Agios Pharmaceuticals (AGIO) Upgraded After Mixed Sickle Cell Data and Pending Thalassemia Catalyst [Yahoo! Finance]
Low
Report
Agios Pharmaceuticals (AGIO) Upgraded After Mixed Sickle Cell Data and Pending Thalassemia Catalyst [Yahoo! Finance]
11/24
09:04 am
agio
Agios Pharmaceuticals (NASDAQ:AGIO) was given a new $32.00 price target on by analysts at Truist Financial Corporation.
Medium
Report
Agios Pharmaceuticals (NASDAQ:AGIO) was given a new $32.00 price target on by analysts at Truist Financial Corporation.
11/24
08:43 am
agio
Agios Pharmaceuticals (NASDAQ:AGIO) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.
Medium
Report
Agios Pharmaceuticals (NASDAQ:AGIO) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.
11/21
02:55 pm
agio
Agios Pharmaceuticals (NASDAQ:AGIO) had its price target lowered by analysts at JPMorgan Chase & Co. from $37.00 to $20.00. They now have a "neutral" rating on the stock.
Low
Report
Agios Pharmaceuticals (NASDAQ:AGIO) had its price target lowered by analysts at JPMorgan Chase & Co. from $37.00 to $20.00. They now have a "neutral" rating on the stock.
11/21
05:30 am
agio
Agios Pharmaceuticals (NASDAQ:AGIO) was upgraded by analysts at Leerink Partnrs from a "hold" rating to a "strong-buy" rating.
Medium
Report
Agios Pharmaceuticals (NASDAQ:AGIO) was upgraded by analysts at Leerink Partnrs from a "hold" rating to a "strong-buy" rating.
11/20
12:26 pm
agio
How Recent Events Are Reshaping the Agios Pharmaceuticals Investment Story [Yahoo! Finance]
Low
Report
How Recent Events Are Reshaping the Agios Pharmaceuticals Investment Story [Yahoo! Finance]
11/20
08:07 am
agio
Agios Pharmaceuticals (NASDAQ:AGIO) had its price target lowered by analysts at HC Wainwright from $56.00 to $48.00. They now have a "buy" rating on the stock.
Medium
Report
Agios Pharmaceuticals (NASDAQ:AGIO) had its price target lowered by analysts at HC Wainwright from $56.00 to $48.00. They now have a "buy" rating on the stock.
11/20
08:07 am
agio
Agios Pharmaceuticals (NASDAQ:AGIO) had its price target lowered by analysts at Bank of America Corporation from $54.00 to $32.00. They now have a "buy" rating on the stock.
Medium
Report
Agios Pharmaceuticals (NASDAQ:AGIO) had its price target lowered by analysts at Bank of America Corporation from $54.00 to $32.00. They now have a "buy" rating on the stock.
11/20
08:07 am
agio
Agios Pharmaceuticals (NASDAQ:AGIO) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $40.00 to $25.00. They now have a "neutral" rating on the stock.
Medium
Report
Agios Pharmaceuticals (NASDAQ:AGIO) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $40.00 to $25.00. They now have a "neutral" rating on the stock.
11/20
08:05 am
agio
Agios Pharmaceuticals (NASDAQ:AGIO) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $34.00 price target on the stock, down previously from $40.00.
Medium
Report
Agios Pharmaceuticals (NASDAQ:AGIO) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $34.00 price target on the stock, down previously from $40.00.
11/19
02:46 pm
agio
Agios Pharma: Study Fail May Affect Mitapivat TDT Approval - Expect More Volatility [Seeking Alpha]
Low
Report
Agios Pharma: Study Fail May Affect Mitapivat TDT Approval - Expect More Volatility [Seeking Alpha]